NIH-CAP 2006-07 Participating Companies - 11/2007

NIH-CAP 2006-07 Participating Companies AbleLink Technologies, Inc. Daniel Davies Colorado Springs, CO Tel: 719-592-0347 Email: [email protected]

AbleLink Technologies™ has pioneered technologies which maximize independence and reduce costs for individuals needing specialized supports to live independently. The HomeLife Technology Suite TM delivers easy to use health care instructions using text, video and audio; provides automated reminders to take medications or perform exercises; tracks activity; and remotely communicates health information. This system enables seniors, their family members or home health care providers to perform health care tasks more accurately, using a unique person-centered approach which does not yet exist in the industry. AbleLink is seeking expansion funding, strategic partners and home health care organizations interested in cost-effective strategies for serving the expanding senior population.

Advanced Liquid Crystal Tech, Patricia Cladis Inc. Tel: 908-273-0187 Summit, NJ Email: [email protected]

A collaboration of physicists and engineers using state-of-the-art techniques and knowledge to turn theory into practice Our products: 1. Hyperpolarimeter - A tool for measuring the magnetization of gases enabling Magnetic Resonance Imaging (MRI) of empty spaces – (lungs, heart, sinuses etc) and tracking of the uptake of oxygen in the brain and other soft tissues in the body. 2. Hyperpolarizer - A portable, fully automated device for polarizing He3, thus enabling MRI of soft tissues and empty spaces, e.g. lungs, sinuses, etc. Our goal is to partner with an existing manufacturer of MRIs and MRI related products to dominate the Hyperpolarized gas market as it develops.

Advanced Liquid Logic Richard West Research Triangle Pk, NC Tel: 919-287-9010 Email: [email protected]

Advanced Liquid Logic’s digital microfluidics is a lab-on-a-chip technology based on direct, programmable manipulation of discrete droplets using electrical fields. It enables complex liquid handling to be implemented in software with no pumps, valves, or pipes. The Company has implemented rapid and sensitive clinical chemistry and immunoassays on chip and has demonstrated the feasibility of PCR and DNA sequencing. Ultimately complex test panels will be performed on low- volume samples with a PDA-like instrument. The Company has the team (10 PhD’s) and the patent position (30 patents issued or pending) to succeed and seeks partners to take products to market.

Advantagene Estuardo Aguilar-Cordova Waban, MA Tel: 617-916-5445 Email: [email protected]

Progression and recurrence after initial cancer therapy is a key underserved and unmet medical need. Advantagene is focused on addressing this need through simple products that improve the outcome of standard radiation, surgery or chemotherapy. Advantagene’s lead technology, Gene Mediated Cytotoxic Immunotherapy (GMCI™), generates a patient-specific response from a non-patient-specific product. It generates an in-situ tumor-specific vaccine for a targeted, systemic response against residual tumor cells or occult micrometastases. GMCI™ can be applied to a variety of tumor types. Advantagene has positive results from a completed Phase 2 and multiple Phase 1 human clinical trials.

AdviTech, Inc. Wesley Krueger San Antonio, TX Tel: 210-697-0880 Sitemap | 2007-08 NIH-CAP